299 related articles for article (PubMed ID: 33787887)
21. Hospital-level high-risk antibiotic use in relation to hospital-associated
Tabak YP; Srinivasan A; Yu KC; Kurtz SG; Gupta V; Gelone S; Scoble PJ; McDonald LC
Infect Control Hosp Epidemiol; 2019 Nov; 40(11):1229-1235. PubMed ID: 31522695
[TBL] [Abstract][Full Text] [Related]
22. Community-Associated Clostridioides difficile Infection in Children: A Review of Recent Literature.
Adams DJ; Barone JB; Nylund CM
J Pediatric Infect Dis Soc; 2021 Nov; 10(Supplement_3):S22-S26. PubMed ID: 34791398
[TBL] [Abstract][Full Text] [Related]
23. Omadacycline and
Garey KW; Rose W; Gunter K; Serio AW; Wilcox MH
Ann Pharmacother; 2023 Feb; 57(2):184-192. PubMed ID: 35656828
[TBL] [Abstract][Full Text] [Related]
24. Investigating the association of room features with healthcare-facility-onset
Root ED; Lindstrom M; Xie A; Mangino JE; Moffatt-Bruce S; Hebert C
Infect Control Hosp Epidemiol; 2021 Jul; 42(7):847-852. PubMed ID: 33261688
[TBL] [Abstract][Full Text] [Related]
25. Correlation between antibiotic consumption and the incidence of healthcare facility-onset Clostridioides difficile infection: a retrospective chart review and analysis.
Yun JH; Park GE; Ki HK
Antimicrob Resist Infect Control; 2021 Aug; 10(1):117. PubMed ID: 34362442
[TBL] [Abstract][Full Text] [Related]
26. Clostridioides difficile infection: Incidence and risk factors in a tertiary care facility in Riyadh, Saudi Arabia.
Alzouby S; Baig K; Alrabiah F; Shibl A; Al-Nakhli D; Senok AC
J Infect Public Health; 2020 Jul; 13(7):1012-1017. PubMed ID: 31831398
[TBL] [Abstract][Full Text] [Related]
27. Inpatient fluoroquinolone use in Veterans' Affairs hospitals is a predictor of
Silva SY; Wilson BM; Redmond SN; Donskey CJ
Infect Control Hosp Epidemiol; 2021 Jan; 42(1):57-62. PubMed ID: 32962774
[TBL] [Abstract][Full Text] [Related]
28. Risk factors for Clostridioides difficile infection in children: a systematic review and meta-analysis.
Dong N; Li ZR; Qin P; Qiang CX; Yang J; Niu YN; Niu XR; Liu XX; Wang WG; Wen BJ; Ouyang ZR; Zhang YL; Zhao M; Li JYR; Zhao JH
J Hosp Infect; 2022 Dec; 130():112-121. PubMed ID: 36108754
[TBL] [Abstract][Full Text] [Related]
29. Saccharomyces boulardii prophylaxis for targeted antibiotics and infectious indications to reduce healthcare facility-onset Clostridioides difficile infection.
Wombwell E
Microbes Infect; 2023; 25(3):105041. PubMed ID: 36058513
[TBL] [Abstract][Full Text] [Related]
30. Temporal change of risk factors in hospital-acquired
Song J; Cohen B; Zachariah P; Liu J; Larson EL
Infect Control Hosp Epidemiol; 2020 Sep; 41(9):1048-1057. PubMed ID: 32468975
[TBL] [Abstract][Full Text] [Related]
31. Healthcare associated
Šuljagić V; Milenković B; Perić A; Jovanović D; Begović-Kuprešanin V; Starčević S; Tomić A; Vezmar Kovačević S; Dragojević-Simić V
Libyan J Med; 2020 Dec; 15(1):1708639. PubMed ID: 31905110
[No Abstract] [Full Text] [Related]
32. Evaluation of a risk assessment model to predict infection with healthcare facility-onset Clostridioides difficile.
Tilton CS; Sexton ME; Johnson SW; Gu C; Chen Z; Robichaux C; Metzger NL
Am J Health Syst Pharm; 2021 Sep; 78(18):1681-1690. PubMed ID: 33954428
[TBL] [Abstract][Full Text] [Related]
33. Surveillance and epidemiology of Clostridioides difficile infection using the national health surveillance network criteria: A 7-year study from Mumbai, India.
Rohra S; Poojary A; Patil P; John S; Michael R; Johnson S; Pardeshi P
Indian J Med Microbiol; 2023; 46():100425. PubMed ID: 37945118
[TBL] [Abstract][Full Text] [Related]
34. Association of ward-level antibiotic consumption with healthcare-associated Clostridioides difficile infections: an ecological study in five German university hospitals, 2017-2019.
Rohde AM; Mischnik A; Behnke M; Dinkelacker A; Eisenbeis S; Falgenhauer J; Gastmeier P; Häcker G; Herold S; Imirzalioglu C; Käding N; Kramme E; Peter S; Piepenbrock E; Rupp J; Schneider C; Schwab F; Seifert H; Steib-Bauert M; Tacconelli E; Trauth J; Vehreschild MJGT; Walker SV; Kern WV; Jazmati N;
J Antimicrob Chemother; 2023 Sep; 78(9):2274-2282. PubMed ID: 37527398
[TBL] [Abstract][Full Text] [Related]
35. A Multicenter Evaluation of Probiotic Use for the Primary Prevention of Clostridioides difficile Infection.
Heil EL; Harris AD; Brown C; Seung H; Thom KA; von Rosenvinge E; Sorongon S; Pineles L; Goodman KE; Leekha S
Clin Infect Dis; 2021 Oct; 73(8):1330-1337. PubMed ID: 33972996
[TBL] [Abstract][Full Text] [Related]
36. Healthcare-associated
Manea E; Jipa R; Milea A; Roman A; Neagu G; Hristea A
Rom J Intern Med; 2021 Dec; 59(4):409-415. PubMed ID: 34053203
[No Abstract] [Full Text] [Related]
37. Potential causal effect of contact precautions and isolation on Clostridioides difficile infection in the hyperendemic setting: Interrupted time-series analyses before and after implementation.
Lee EH; Lee HS; Lee KH; Song YG; Han SH
J Microbiol Immunol Infect; 2023 Oct; 56(5):1054-1063. PubMed ID: 37380552
[TBL] [Abstract][Full Text] [Related]
38. Clostridioides difficile incidence related to in-hospital cephalosporin use: a tale of two highly comparable hospitals.
Karp J; Edman-Wallér J; Toepfer M; Lundqvist A; Jacobsson G
J Antimicrob Chemother; 2019 Jan; 74(1):182-189. PubMed ID: 30358837
[TBL] [Abstract][Full Text] [Related]
39. Association between antiulcer agents and Clostridioides difficile infection in patients receiving antibiotics: A retrospective cohort study using the diagnosis procedure combination database in Japan.
Ishida R; Seki T; Kawakami K
Anaerobe; 2022 Jun; 75():102537. PubMed ID: 35202792
[TBL] [Abstract][Full Text] [Related]
40. Community-onset Clostridium difficile infection at a tertiary medical center in southern Taiwan, 2007-2015.
Tsai CS; Hung YP; Lee JC; Lee NY; Chen PL; Syue LS; Li MC; Li CW; Ko WC
J Microbiol Immunol Infect; 2018 Apr; 51(2):243-250. PubMed ID: 28089100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
